Register Today

Dexcom Wear & Learn
Take-Home Sensor Trial Program


Experience offered at
The 2026 AANP National Conference



Gain direct experience and practical insights through real-world application.

Register for a free educational trial designed to give participants a unique, hands-on opportunity to experience Dexcom G7 15 Day or Stelo by Dexcom from the user perspective. Participants will receive a sensor to take home and explore personalized glucose insights through the in-app features.

Participation in this experience is first come, first served. Registration is required. Sensors must be taken off‑site for trial use. Application of the sensor is not permitted in the booth. Participants may only trial one product.

Dexcom G7 15 Day

Eligibility Requirements:
Participants must
  • Be a prescriber with an active NPI number
  • Be licensed in the United States
  • Be an adult 18 years or older
  • Be unfamiliar with Dexcom G7 15 Day and need further education
  • Have a compatible smartphone*

Stelo by Dexcom

Eligibility Requirements:
Participants must
  • Be a licensed healthcare professional—prescribing or non-prescribing—or a healthcare student
  • Be a resident of the United States
  • Be an adult 18 years or older not on insulin
  • Be unfamiliar with Stelo and need further education
  • Have a compatible smartphone*
This educational trial is exclusively for United States licensed healthcare professionals and healthcare students. Industry participants and healthcare professionals licensed in Vermont are not eligible to participate.
REGISTER TODAY
WHEN

June 25 - 27

WHERE

AANP Exhibit Hall, Booth #665

Get to know
the Dexcom portfolio

PRODUCT HIGHLIGHT

Dexcom G7 15 Day

Prescribe G7 15 Day for adult patients 18+ with‡:

  • Type 1 or type 2 diabetes, regardless of insulin use1
  • Diabetes during pregnancy1
  • AID (automated insulin delivery) system
  • Most-covered CGM for all types of diabetes§,2
  • Available at pharmacies and DME suppliers

Learn more about Dexcom G7 15 Day
Side image
PRODUCT HIGHLIGHT

Stelo by Dexcom

Recommend Stelo for adult patients aged 18+ with‡, 3:

  • Prediabetes
  • An interest in tracking their glucose for health insights
  • Type 2 diabetes not on insulin who do not have insurance coverage for CGM
  • No prescription needed

Learn more about Stelo by Dexcom
Side image
This program is not part of the 2026 AANP National Conference as planned by the American Association of Nurse Practitioners. This event is neither sponsored nor endorsed by the American Association of Nurse Practitioners. This event does not qualify for continuing medical education (CME) credit.

*Results with Dexcom CGM have been proven in over 70 clinical studies, data available on clinicaltrials.gov. † For Dexcom G7 compatible devices, visit dexcom.com/compatibility. For Stelo app compatibility information, visit stelo.com/compatibility. ‡For adults 18 years and older. §Individual coverage may vary depending on insurance plan.

1 Dexcom G7 15 Day User Guide. 2 Data on file (VV-06805). Dexcom; 2025. 3 Stelo User Guide.

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

© 2026 Dexcom, Inc. All rights reserved.
MAT-13796